title: [Role of gemcitabine in treatment of metastatic breast cancer].
authors.forename: D Kh
authors.initials: DKh
authors.lastname: Latipova
authors.forename: T Iu
authors.initials: TIu
authors.lastname: Semiglazova
authors.forename: L V
authors.initials: LV
authors.lastname: Filatova
authors.forename: M L
authors.initials: ML
authors.lastname: Gershanovich
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D017239:Paclitaxel / Q000008:administration & dosage; D000068878:Trastuzumab; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000068878:Trastuzumab; D017239:Paclitaxel; D000093542:Gemcitabine